← Leaderboards
Stefan Ambs
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorTumor BiologyMalignant Neoplasm Of ProstateTissuesCollaborationsMolecular ProfilingEuropeanAfrican AmericanAmericanInflammationMalignant NeoplasmsPathway InteractionsProstatic NeoplasmsLinkGene ExpressionCancer PatientSurveysPilot ProjectsRaceGeneticMarylandAffectBaseGenes
Grant awards (68)
Novel Markers for Disease Outcome in Breast Cancer$721,279
ZIA · FY2025 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$540,958
ZIA · FY2025 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$540,958
ZIA · FY2025 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$1,188,833
ZIA · FY2024 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$891,624
ZIA · FY2024 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$891,624
ZIA · FY2024 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$1,159,062
ZIA · FY2023 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$869,296
ZIA · FY2023 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$869,296
ZIA · FY2023 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$913,469
ZIA · FY2022 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$685,102
ZIA · FY2022 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$685,102
ZIA · FY2022 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$907,363
ZIA · FY2021 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$680,523
ZIA · FY2021 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$680,523
ZIA · FY2021 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$944,569
ZIA · FY2020 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$708,426
ZIA · FY2020 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$708,426
ZIA · FY2020 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$759,873
ZIA · FY2019 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$759,873
ZIA · FY2019 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$284,952
ZIA · FY2019 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$94,984
ZIA · FY2019 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$563,569
ZIA · FY2018 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$563,569
ZIA · FY2018 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$211,339
ZIA · FY2018 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$70,446
ZIA · FY2018 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$723,107
ZIA · FY2017 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$723,107
ZIA · FY2017 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$271,166
ZIA · FY2017 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$90,389
ZIA · FY2017 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$712,287
ZIA · FY2016 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$623,251
ZIA · FY2016 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$356,143
ZIA · FY2016 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$89,035
ZIA · FY2016 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$673,686
ZIA · FY2015 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$589,474
ZIA · FY2015 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$336,842
ZIA · FY2015 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$84,210
ZIA · FY2015 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$595,046
ZIA · FY2014 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$520,666
ZIA · FY2014 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$297,523
ZIA · FY2014 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$74,380
ZIA · FY2014 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$666,640
ZIA · FY2013 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$583,310
ZIA · FY2013 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$333,319
ZIA · FY2013 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$83,330
ZIA · FY2013 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$668,844
ZIA · FY2012 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$418,028
ZIA · FY2012 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$334,423
ZIA · FY2012 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$167,211
ZIA · FY2012 · CA · contact PI
The Molecular Profile of Prostate Tumors in Smokers$83,605
ZIA · FY2012 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$510,914
ZIA · FY2011 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$255,457
ZIA · FY2011 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$255,457
ZIA · FY2011 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$191,593
ZIA · FY2011 · CA · contact PI
The Molecular Profile of Prostate Tumors in Smokers$63,864
ZIA · FY2011 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$699,227
ZIA · FY2010 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$437,016
ZIA · FY2010 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$349,613
ZIA · FY2010 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$174,807
ZIA · FY2010 · CA · contact PI
The Molecular Profile of Prostate Tumors in Smokers$87,404
ZIA · FY2010 · CA · contact PI
Maryland Prostate Cancer Case-Control Study$770,424
ZIA · FY2009 · CA · contact PI
The Molecular Profile of Prostate Tumors in African-American Men$481,515
ZIA · FY2009 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$288,909
ZIA · FY2009 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$192,606
ZIA · FY2009 · CA · contact PI
The Molecular Profile of Prostate Tumors in Smokers$192,606
ZIA · FY2009 · CA · contact PI
Novel Markers for Disease Outcome in Breast Cancer$224,251
Z01 · FY2008 · CA · contact PI
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer$224,251
Z01 · FY2008 · CA · contact PI